Stem cell therapy for SCA3 ataxia
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a stem cell therapy called Stemchymal® for people with a specific type of hereditary ataxia (SCA3). It aims to see if the treatment can improve balance and coordination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a genetic test that confirms you have SCA3 (also called Machado-Joseph disease).
- Your balance and coordination score (SARA score) should be between 5 and 15.
- You need to be between 20 and 70 years old.
- If you could become pregnant, you must be past menopause, have had surgery to prevent pregnancy, or use effective birth control. If you could father a child, you must use contraception.
- You cannot have had any cell therapy in the last 6 months, or have serious heart, liver, lung, or kidney disease, or immune disorders, or other neurological conditions like Alzheimer's.
- You cannot have had cancer or chemotherapy/radiation in the last 5 years, or have dementia or severe depression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) can improve balance and coordination in people with hereditary spinocerebellar ataxia. If you have a confirmed genetic diagnosis of SCA1, 2, or 3 and are between 18 and 65, you may be eligible.
This Phase 2 study tests an umbilical cord “stem cell” treatment to improve symptoms in people with spinocerebellar ataxia (a nerve condition that affects balance and walking). It may help walking ability and overall ataxia symptoms, but you must meet specific health and lab safety checks.
This trial tests a non-invasive brain stimulation method called transcranial temporal interference stimulation to see if it can improve symptoms of spinocerebellar ataxia type 3 (a condition affecting balance and coordination). It aims to find the best stimulation settings to help with movement and gait.
This trial tests whether deep brain stimulation (DBS) can improve walking and coordination in people with SCA1 or SCA3, two genetic conditions that cause ataxia. If you are an adult with moderate ataxia, this might be a new option to explore.
This trial tests whether a special type of stem cell (neuroinduced mesenchymal stem cells) and their exosomes can safely help people with spinocerebellar palsy. It's an early study focusing on safety and possible improvement in symptoms.
This study tests a new kind of deep brain stimulation that adjusts automatically to improve balance and coordination in adults with SCA6, a genetic form of ataxia. It may help patients who can still walk but have moderate to severe symptoms.
Hear when a new Spinocerebellar Ataxias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.